Has Cecilia Uga received payments from drug or device companies?

Yes. Drug and device makers reported $9,115 in general payments to Cecilia Uga across 386 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Cecilia Uga did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Cecilia Uga come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Cecilia Uga

Psychiatric/Mental Health · El Paso, TXNPI 1336670199

Payments from drug & device makers

$9,115in general payments, 2019–2025

Across 386 payments — averaging $23.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$2K
AbbVie$944
Takeda Pharmaceuticals U.S.A., Inc.$927
Teva Pharmaceuticals USA, Inc.$879
Lundbeck LLC$804
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$642
plus $3K from 14 others

What the payments were for

Food & beverage$9,00299%
Education$1131%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson	47	$1,676
AbbVie	47	$944
Takeda Pharmaceuticals U.S.A., Inc.	54	$927
Teva Pharmaceuticals USA, Inc.	27	$879
Lundbeck LLC	36	$804
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	34	$642
Otsuka America Pharmaceutical, Inc.	27	$574
Neurocrine Biosciences, Inc.	20	$558
Axsome Therapeutics, Inc.	21	$470
Alkermes, Inc.	19	$454
Vanda Pharmaceuticals Inc.	18	$387
E.r. Squibb & Sons, L.L.C.	12	$336
Idorsia Pharmaceuticals US Inc	10	$154
Sage Therapeutics, LLC	6	$103
Brainsway USA Inc	2	$87
Tonix Medicines, Inc.	2	$36
Jazz Pharmaceuticals Inc.	1	$25
Harmony Biosciences LLC	1	$21
Corium, LLC	1	$21
AstraZeneca	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,115 in reported general payments places this provider in the 95th percentile of 2,724 psychiatric/mental health providers in Texas.

See all psychiatric/mental health providers in Texas →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Venlafaxine Hcl ErVenlafaxine Hcl	11	$441
Mirtazapine	14	$396

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in El Paso

Victor IlogEl Paso$167K
Alfredo ArellanoEl Paso$55K
Tracy HicksLongview$684K
Natalie TellezHouston$602K
Karah BrashierRichardson$567K
Grant DavisRichardson$360K
Lisa ShamblinGrapevine$163K
Monique GonzalezSan Antonio$126K
Marguerite AddisonWaco$118K
Komi Kokou-AbiRound Rock$88K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →